At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,120 enrolled
Drug / intervention
ION™ Coronary Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
In Brief
An observational study evaluating ION™ Coronary Stent System for Atherosclerosis and Coronary Artery Disease. Completed, enrolled 1,120 participants across 40 sites.
Detailed Summary
The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Coronary Artery Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartSep 2011
Primary CompletionJun 2013
Study CompletionFeb 2015
TodayJul 2026
First PostedAug 25, 2011
Enrollment StartSep 1, 2011
Primary CompletionJun 1, 2013
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 14.9 years ago
Interventions
ION™ Coronary Stent Systemdevice
This study is intended to evaluate the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System across a range of institutions and physician users to observe and assess subject outcomes and technology performance in a real-world setting.